Home

"Unknown translocation partners that drive expression of oncogenes as consequence of cryptic or previous unidentified chromosomal rearrangements were identified in T-cell leukemia patients using Targeted Locus Amplification.”

Princess Máxima Center for Pediatric Oncology
Dr. Jules Meijerink - PI

"TLA analysis has proven to be very useful to quality control genetically engineered cell lines”

AstraZeneca
Dr. John Wiseman - Associate Director
  • Latest news

  • Empowering advanced genetic engineering
    &
    precision medicine

  • Upcoming events

    19 | 10 | 2021 / 22 | 10 | 2021 - Conferences
    Read more
    28 | 10 | 2021 / 29 | 10 | 2021 - Conferences
    Read more
  • APPNOTES

    Read more
  • TLA technology

    Read more
  • Publications

    Read more
© 2012-2021 Cergentis B.V. All rights reserved.
For Research Use Only.Not for use in diagnostic procedures.
We use cookies for website analysis and marketing. By visiting and using our website you accept these cookies.
ACCEPT